Displaying drugs 13301 - 13325 of 14095 in total
Motexafin lutetium
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
Matched Iupac: … lutetium(3+) 4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis({2-[2-(2-methoxyethoxy)ethoxy]ethoxy})-10,23 …
Matched Description: … It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. ... Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer …
Matched Description: … It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. ... Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer …
Pipazethate
A non-narcotic oral antitussive agent.
Experimental
Matched Iupac: … -hexaene-2-carboxylate ... 2-[2-(piperidin-1-yl)ethoxy]ethyl 9-thia-2,4-diazatricyclo[8.4.0.0^{3,8}]tetradeca-1(14),3(8),4,6,10,12 …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Enoblituzumab
Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).
Investigational
Matched Description: … Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children …
Batabulin
Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive, Unresectable, Hepatocellular Carcinoma Patients).
Investigational
Matched Description: … Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive …
Dihematoporphyrin ether
Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).
Investigational
Matched Iupac: … 3-[15-(1-{1-[10,14-bis(2-carboxyethyl)-19-(1-hydroxyethyl)-5,9,15,20-tetramethyl-21,22,23,24-tetraazapentacyclo ... 3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-4-yl]ethoxy}ethyl)-20-(2- …
Matched Description: … Dose PDT in Glioma). ... Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light …
Matched Description: … Dose PDT in Glioma). ... Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light …
PF-04856884
PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination With Axitinib in Patients With Previously Treated Metastatic Renal Cell Carcinoma).
Investigational
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination ... With Axitinib in Patients With Previously Treated Metastatic Renal Cell Carcinoma). …
Virginiamycin M1
Pristinamycin IIA is a macrolide antibiotic, a member of the streptogramin A group of antibiotics, and one component of pristinamycin. It is produced by Streptomyces graminofaciens and other bacteria.
Experimental
Matched Iupac: … (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-(propan-2-yl)-9,26-dioxa-3,15,28-triazatricyclo …
Matched Description: … Pristinamycin IIA is a macrolide antibiotic, a member of the streptogramin A group of antibiotics, and ... one component of pristinamycin. …
Matched Description: … Pristinamycin IIA is a macrolide antibiotic, a member of the streptogramin A group of antibiotics, and ... one component of pristinamycin. …
Sivifene
Investigational
Matched Iupac: … 4-{[2-(2,4-dinitrophenyl)hydrazin-1-ylidene](4-hydroxyphenyl)methyl}phenol …
Tanomastat
Investigational
Matched Iupac: … (2S)-4-{4'-chloro-[1,1'-biphenyl]-4-yl}-4-oxo-2-[(phenylsulfanyl)methyl]butanoic acid …
Repifermin
Investigational
Enzastaurin
Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer.
Investigational
Matched Iupac: … 3-(1-methyl-1H-indol-3-yl)-4-(1-{1-[(pyridin-2-yl)methyl]piperidin-4-yl}-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole …
Matched Description: … relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer. ... investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer. ... investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Minodronic acid
Investigational
Matched Iupac: … (1-hydroxy-2-{imidazo[1,2-a]pyridin-3-yl}-1-phosphonoethyl)phosphonic acid …
VP025
VP025, a novel drug formulation based on phospholipid microparticles incorporating phosphatidylglycerol, can inhibit neuroinflammation. VP025 may inhibit immune system activation and protect motoneurons from injury. It also shows the ability to reduce inflammation across the blood-brain barrier and improve correlates of memory and learning function. It is being developed to...
Investigational
Matched Description: … also shows the ability to reduce inflammation across the blood-brain barrier and improve correlates of ... target the chronic inflammation within the central nervous system that is associated with a number of …
TH0318
TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.
Investigational
Matched Description: … treatment of type 2 diabetes. ... TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the …
SR-123781A
SR-123781A is a synthetic hexadecasaccharide Factor IIa and Xa antagonist. It is under investigation by Sanofi-Aventis and Organon for the treatment of thrombosis and acute coronary syndromes (ACS).
Investigational
Matched Description: … It is under investigation by Sanofi-Aventis and Organon for the treatment of thrombosis and acute coronary …
OPC-14523
OPC-14523 is an antidepressant drug developed by Otsuka America Pharmaceutical.
Investigational
Matched Iupac: … 1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-methoxy-1,2,3,4-tetrahydroquinolin-2-one …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Cositecan
Cositecan is the novel camptothecin derivative which is also known as Karenitecin. It has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.
Investigational
Matched Iupac: … (19S)-19-ethyl-19-hydroxy-10-[2-(trimethylsilyl)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^ …
NV-07a
NV-07a is topical skin repair compound protecting skin from sun-induced immunosuppression and UV-induced damage.
Investigational
Adomiparin
Investigational
Tesofensine
Investigational
Matched Iupac: … (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane …
Matched Salts cas: … 861205-83-6 …
Matched Salts cas: … 861205-83-6 …
G4460
Investigational
Ravuconazole
Investigational
Matched Iupac: … 4-{2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl} …
Vitespen
Investigational
MultiStem
MultiStem is an intravenously-administered, off-the-shelf proprietary product developed which comprises Multipotent Adult Progenitor Cells (MAPCs). Like mesenchymal stem cells, MAPCs are derived from bone-marrow stroma and are non-hematopoietically adherent. They have immunomodulatory and pro-angiogenic properties while also being mostly non-immunogenic. Additional benefits of MultiStem include their low immunogenicity, meaning they...
Investigational
Matched Description: … The cells for creation of the product are isolated from a qualified donor and expanded on a large scale ... Additional benefits of MultiStem include their low immunogenicity, meaning they can be administered without …
Displaying drugs 13301 - 13325 of 14095 in total